Gene · 81848
Papers1,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EZH2: A Crucial Competing Endogenous RNA in Cancer Research-A Scoping Review. | Adv Biomed Res | 2025 | 40519579 | PubTator, text mining | PubMed |
| Dual Regulation of Sprouty 4 Palmitoylation by ZDHHC7 and Palmitoyl-Protein Thioesterase 1: A Potential Therapeutic Strategy for Cisplatin-Resistant Osteosarcoma. | Research (Wash D C) | 2025 | 40416361 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| [Clinicopathological features of primary thoracic synovial sarcoma: a study of 42 cases]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 40302578 | PubTator, text mining | PubMed |
| Oligogenic analysis across broad phenotypes of 46,XY differences in sex development associated with NR5A1/SF-1 variants: findings from the international SF1next study. | EBioMedicine | 2025 | 40037090 | PubTator, text mining | PubMed |
| PROKR2 mutations and SPRY4 variants with uncertain significance in a Kallmann syndrome family: Incomplete penetrance. | Glob Med Genet | 2025 | 40034250 | PubTator, text mining | PubMed |
| Deciphering the dose-dependent effects of thymoquinone on cellular proliferation and transcriptomic changes in A172 glioblastoma cells. | PLoS One | 2025 | 39874307 | PubTator, text mining | PubMed |
| A heterozygous SPRY4 variant identified in female infertility characterized by reduced oocyte potential and early embryonic arrest. | Hum Reprod | 2024 | 39348320 | PubTator, text mining | PubMed |
| SPRY4 regulates ERK1/2 phosphorylation to affect oxidative stress and steroidogenesis in polycystic ovary syndrome. | Steroids | 2024 | 39313103 | PubTator, text mining | PubMed |
| ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers. | Mol Cancer Ther | 2024 | 39295275 | PubTator, text mining | PubMed |
| Mdm2 requires Sprouty4 to regulate focal adhesion formation and metastasis independent of p53. | Nat Commun | 2024 | 39164253 | PubTator, text mining | PubMed |
| Correction: Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis. | Biosci Rep | 2024 | 39081203 | PubTator, text mining | PubMed |
| Knockdown of miR-1293 attenuates lung adenocarcinoma angiogenesis via Spry4 upregulation-mediated ERK1/2 signaling inhibition. | Biochem Pharmacol | 2024 | 38972427 | PubTator, text mining | PubMed |
| Role of SPRY4 in health and disease. | Front Oncol | 2024 | 38686189 | PubTator, text mining | PubMed |
| Sprouty genes regulate activated fibroblasts in mammary epithelial development and breast cancer. | Cell Death Dis | 2024 | 38600092 | PubTator, text mining | PubMed |
| Primary osteoarthritis chondrocyte map of chromatin conformation reveals novel candidate effector genes. | Ann Rheum Dis | 2024 | 38479789 | PubTator, text mining | PubMed |
| Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. | Clin Exp Med | 2024 | 38294554 | PubTator, text mining | PubMed |
| Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. | Int J Mol Sci | 2024 | 38279330 | PubTator, text mining | PubMed |
| Identification of a Novel Germline PPP4R3A Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma. | Biomedicines | 2024 | 38275415 | PubTator, text mining | PubMed |
| Impact of polygenic score for BMI on weight loss effectiveness and genome-wide association analysis. | Int J Obes (Lond) | 2024 | 38267484 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81848/papers?page=2